Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Wulandari Bangun Laksana Tbk (BSBK) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Wulandari Bangun Laksana TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Wulandari Bangun Laksana Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Wulandari Bangun Laksana Tbk trades at Rp54 (market cap 1.35T, 13.3M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Wulandari Bangun Laksana Tbk is far larger — about 2.1× UBC Medical Indonesia Tbk.'s market cap, and Wulandari Bangun Laksana Tbk is more actively traded (13.3M versus 843K). Which is the better fit depends on your goals.

BSBKLABS
Market Cap
1.35T635.95B
Volume
13.3M843K
Lot
133.05K8.43K
Turnover
704.37M137.6M
Average Price
52.94163.22
Value
704.37M137.6M
Indicative Equilibrium Price
54165
Indicative Equilibrium Volume
1.49K246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BSBK
View details
LABS
View details

About Wulandari Bangun Laksana Tbk

PT Wulandari Bangun Laksana Tbk (the “Company”) was established under the name PT Dwipagrya Lestari in Jakarta based on Deed No. 21 dated September 7, 1994 by Linda Ibrahim, S.H., Notary in Jakarta. The Company commended its commercial operations on 2005.

Read more on BSBK

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS